ArticleBiosensors2026
Competitive Immunoassay of Melatonin by QCM Biosensor.
Article in Biosensors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Melatonin is a hormone that plays a role in the regulation of circadian rhythms and is also recognized for its antioxidant and cytoprotective functions. Its determination in biological samples is analytically challenging because the physiological concentration is very low, especially in saliva. Here, a competitive immunoassay based on a quartz crystal microbalance (QCM) biosensor was developed for melatonin determination. The biosensor employed a surface modified with a melatonin-albumin conjugate and a multilayer antibody amplification scheme to enhance the piezoelectric response. The assay was calibrated in the low picogram per liter range and provided a limit of detection of 0.55 pg/mL (2.37 pmol/mL) for a 25 µL sample. The analytical performance was sufficient for the determination of physiological melatonin concentrations in saliva and blood. The assay showed satisfactory selectivity against selected potential interferents and correlated strongly with a standard ELISA method, with a coefficient of determination of r
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.